#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vitamin B12 deficiency Craniopharyngioma Kearns-Sayre syndrome Transitional cell carcinoma Haemophilia A without inhibitors Glomerulonephritis acute Retinitis pigmentosa Progressive supranuclear palsy Demyelination Systemic scleroderma Malignant neoplasm of choroid Hereditary haemorrhagic telangiectasia Cardiac amyloidosis Antiphospholipid antibodies Conjunctivitis allergic More trials…

    Learn about Rare Diseases

    Hyperoxaluria – Treatment Glomerulonephritis rapidly progressive – Treatment Idiopathic pulmonary fibrosis – Trials in Disease Toxic epidermal necrolysis – Trials in Disease Brain stem glioma – Trials in Disease Cytokine release syndrome – Life with Disease Myelodysplastic syndrome Mitochondrial myopathy – Life with Disease Myelodysplastic syndrome with excess blasts – Diagnostics Factor VIII deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Allo-647 Ly3537982 Asfotase Alfa Acemetacin Citalopram Hydrochloride Desloratadine Mercaptopurine Tilsotolimod Sodium Charcoal, Activated Alendronate Sodium Monohydrate Magrolimab VTX-002 Lidocaine Hydrochloride Deferoxamine Mesilate Ranitidine Tapderimotide Soya Oil Bempedoic Acid Kd050 Emiplacel More therapies…

    Learn about Your Condition

    Seizure Gaucher's disease type III Skin ulcer Morning sickness Hairy cell leukaemia recurrent Meniscus operation Malignant melanoma stage II Endocarditis Chondrocalcinosis Insomnia Glomerulonephritis acute Neonatal asphyxia Obesity Trigeminal neuralgia Fallopian tube cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Oral Arsenic Trioxide for Patients with Low-Risk Myelodysplastic Syndromes Not Responding to Erythropoiesis Stimulating Agents and Luspatercept

    Recruiting

    1 1 1
    Investigated Drugs:
    • Arsenic Trioxide
    France

  • Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Amivantamab
    • Bevacizumab
    • Cetuximab
    Belgium France Germany Hungary Italy The Netherlands +4

  • Study on the Effect of Carvedilol for Patients with Cirrhotic Portal Hypertension

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Carvedilol
    France

  • Study on Meropenem Dosing for Patients with Serious Infections in Intensive Care

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Linezolid
    Norway

  • Study on Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa Using Skin Grafts with Genetically Corrected Autologous Keratinocytes and Fibroblasts

    Recruiting

    2 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • AUTOLOGOUS KERATINOCYTES AND FIBROBLASTS TRANSDUCED WITH A RETROVIRAL VECTOR ENCODING COL7A1 CDNA
    France

  • Study on Preventing Atrial Fibrillation After Heart Surgery Using Landiolol Hydrochloride in Patients with Normal Heart Function

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ejection fraction normal
    • Sinus rhythm
    Investigated Drugs:
    • Landiolol Hydrochloride
    Austria
Previous Page
1 … 243 244 245 246 247 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!